Colin Reisner

Colin Reisner

Directeur Général chez
Pearl Therapeutics, Inc.
Health Technology
Consumer Services
Commercial Services

Profil

Colin Reisner is currently Chief Executive Officer at Pearl Therapeutics, Inc. since 2007 and a Member of the American Thoracic Society, Inc. Former positions include Executive Director-Global Respiratory Development at Novartis Corp., Senior Director-Respiratory Division at GlaxoSmithKline, Inc., Head-Clinical Respiratory at AstraZeneca PLC, Assistant Consulting Professor at Duke University, Assistant Consulting Professor at Yale University, and Principal at Boehringer Ingelheim Corp.
Education includes undergraduate studies at the University of the Witwatersrand.

Postes actifs de Colin Reisner

SociétésPosteDébut
Directeur Général 01/10/2007
Corporate Officer/Principal -

Anciens postes connus de Colin Reisner

SociétésPosteFin
ASTRAZENECA PLC Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Colin Reisner

Formation de Colin Reisner

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

30

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Colin Reisner
🔇